Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid LeukemiaDaniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 MutationAshley Woods, Kelly J Norsworthy, Xin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2025
FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHDKelly J Norsworthy, Donna R Rivera, Joseph Wynne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 MutationE Dianne Pulte, Kelly J Norsworthy, Yaping Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2023
Considerations for Drug Development in Myelodysplastic SyndromesMikkael A Sekeres, Nina Kim, Amy E DeZern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid LeukemiaKelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2023
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and EthnicityDianne Pulte, Laura Fernandes, Guo Wei, et al.
The Oncologist|May 31, 2022
FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC TrialE Dianne Pulte, Haiyan Chen, Lauren S L Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 MutationKelly J Norsworthy, Lola Luo, Vicky Hsu, et al.
Pageof 4